TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05646862 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05646862 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05646862 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06365437 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT06377566 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06267729 — Predictive Biomarker (PRD): STEAP2 mRNA
Genes: STEAP2; PCANAP1; STAMP1; UNQ6507/PRO23203
Study NCT05605522 — Predictive Biomarker (PRD); Safety Biomarker (SAF): NTSR1 mRNA
Genes: NTSR1; NTRR
Study NCT04435249 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05440422 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05919797 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT05919797 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT05919797 — Predictive Biomarker (PRD): ANKK1 mRNA
Genes: ANKK1; PKK2; SGK288
Study NCT04149821 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06464185 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06785636 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06606236 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT06604897 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05512377 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05512377 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05730543 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05501054 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT05825183 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT05740982 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04219319 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06370546 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06080178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04339751 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT06283758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05890794 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study NCT06244082 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06373926 — Predictive Biomarker (PRD): ANXA2 mRNA
Genes: ANXA2; ANX2; ANX2L4; CAL1H; LPC2D
Study NCT06373926 — Predictive Biomarker (PRD): S100A10 mRNA
Genes: S100A10; ANX2LG; CAL1L; CLP11
Study NCT05747937 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05747937 — Predictive Biomarker (PRD): TARDBP mRNA
Genes: TARDBP; TDP43
Study NCT04524000 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04524000 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04524000 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05673785 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05557539 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06495567 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT06370962 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06120283 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06120283 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06120283 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06120283 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06120283 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05861986 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06503146 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06303193 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT06303193 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study NCT06303193 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06303193 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05223907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06179160 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05719441 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05031078 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05967689 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05967689 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05758077 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05331170 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06359041 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06220201 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04585477 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05960578 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05960578 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05964465 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT05395117 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05395117 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT05017792 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05605587 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study NCT05687877 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06379217 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT06379217 — Predictive Biomarker (PRD): GRPR mRNA
Genes: GRPR
Study NCT04774536 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04774536 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04961541 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04992065 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05352698 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05781152 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06799065 — Predictive Biomarker (PRD): KIF18A mRNA
Genes: KIF18A; OK/SW-cl.108
Study NCT06527248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06799182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06799260 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06799260 — Safety Biomarker (SAF): BDNF
Study NCT06020066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05254132 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06508658 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06287593 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05727176 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT06798350 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06799650 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06798623 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06793215 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05273528 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06799715 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT06799715 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT06799715 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06799715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06799611 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06798207 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06798207 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06797609 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06797609 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06797609 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT06797531 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06797531 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06796231 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06796686 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06796699 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT06795607 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06795607 — Safety Biomarker (SAF): Interleukin 1
Study NCT06795607 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT06795607 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06797960 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06606184 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06799026 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06605898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06793709 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT06800027 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06800027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06798896 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT06800196 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT06798558 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06798272 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT06798272 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06798116 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06799234 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04878328 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06799338 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06799338 — Surrogate Endpoint (SUR): Undetectable plasma HIV RNA
Study NCT06799442 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06797999 — Predictive Biomarker (PRD): MRC2 mRNA
Genes: MRC2; CLEC13E; ENDO180; KIAA0709; UPARAP
Study NCT04821674 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06798649 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05679544 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05941338 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05778071 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05392790 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05056220 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06339242 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05687032 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05828069 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04576117 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06399510 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06399510 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05411081 — Predictive Biomarker (PRD): PRCC mRNA
Genes: PRCC; TPRC
Study NCT00000886 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001109 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06432192 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06582875 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT06582706 — Predictive Biomarker (PRD): HCAR2 mRNA
Genes: HCAR2; GPR109A; HCA2; HM74A; NIACR1
Study NCT06577467 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05098405 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05098405 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05898854 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04859985 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT06434883 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04730778 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04652726 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04652726 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05678205 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05467891 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05467891 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05467891 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05392855 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04649359 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04649359 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06401759 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04530565 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04530565 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05708638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05719558 — Predictive Biomarker (PRD): CLDN4 mRNA
Genes: CLDN4; CPER; CPETR1; WBSCR8
Study NCT06601296 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT06605690 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06605690 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06600763 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05889182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04557956 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06760260 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04799275 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT04799275 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT04799275 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study NCT06761963 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06429761 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05337943 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04726033 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06527365 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06484972 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06165341 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT06065059 — Predictive Biomarker (PRD): USP1 mRNA
Genes: USP1
Study NCT06574854 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06574854 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06574854 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05548881 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05138263 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06404047 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05789602 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT04693598 — Predictive Biomarker (PRD): GALC mRNA
Genes: GALC
Study NCT06075147 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06075147 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04342962 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05559580 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05642221 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study NCT05642221 — Predictive Biomarker (PRD): CLN3 mRNA
Genes: CLN3; BTS
Study NCT06562348 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05950945 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05950945 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05950945 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05950945 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05456685 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT05920356 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06445985 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05957432 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT05333432 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05333432 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05333432 — Predictive Biomarker (PRD): HOXB13 mRNA
Genes: HOXB13
Study NCT06310187 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06163430 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06163430 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05856591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05782335 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05782335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06096038 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CSPG4 mRNA
Genes: CSPG4; MCSP
Study NCT05971433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05705258 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06557785 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT06557785 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05678348 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT05678348 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT05678348 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT05435495 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05994157 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04529031 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04529031 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT04529031 — Predictive Biomarker (PRD): DDX6 mRNA
Genes: DDX6; HLR2; RCK
Study NCT04529031 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT04529031 — Predictive Biomarker (PRD): LAIR1 mRNA
Genes: LAIR1; CD305
Study NCT04529031 — Predictive Biomarker (PRD): RTN4 mRNA
Genes: RTN4; KIAA0886; NOGO; My043; SP1507
Study NCT05480436 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06384274 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06639919 — Predictive Biomarker (PRD): SDC1 mRNA
Genes: SDC1; SDC
Study NCT06639919 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06639919 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06263673 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06263673 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06565442 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06643377 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06058377 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06058377 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06058377 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06058377 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05554328 — Safety Biomarker (SAF): RAS pathway
Study NCT06535308 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05160597 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06030609 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06030609 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05065970 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04966481 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT06801327 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06801431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06157216 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06801262 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06801366 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05707273 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05698901 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05698901 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT06247111 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06801002 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study NCT06801990 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06801236 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP11A1 mRNA
Genes: CYP11A1; CYP11A
Study NCT06801249 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06801600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06801015 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT06801028 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT06377852 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06377852 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06377852 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06561685 — Predictive Biomarker (PRD): SMARCA2 mRNA
Genes: SMARCA2; BAF190B; BRM; SNF2A; SNF2L2
Study NCT05645536 — Predictive Biomarker (PRD): HR mRNA
Genes: HR